SPY335.84-2.98 -0.88%
DIA279.57-1.46 -0.52%
IXIC10,910.28-140.19 -1.27%

Monopar Therapeutics Q1 EPS $(0.100) Up From $(0.150) YoY

Monopar Therapeutics (NASDAQ:MNPR) reported quarterly losses of $(0.100) per share. This is a 33.33 percent increase over losses of $(0.150) per share from the same period last year.

Benzinga · 05/07/2020 13:14

Monopar Therapeutics (NASDAQ:MNPR) reported quarterly losses of $(0.100) per share. This is a 33.33 percent increase over losses of $(0.150) per share from the same period last year.